In our latest podcast, Specialist nurse and educator Kate Davies asks clinical psychologist Julie Alderson about the optimal integration of psychology into a differences in sexual development clinical service.
In our latest podcast, Professor Sadaf Farooqi discusses the most recent findings from the Genetics Of Obesity Study, and what they mean for families and children with severe early-onset obesity.
Our podcast features Dr Salvatore Vaccarella, from the International Agency for Research on Cancer in Lyon, France, lead author of a recent article in The Lancet Diabetes & Endocrinology indicating that thyroid cancer overdiagnosis is a concern for children and adolescents.
Dr Cheri Deal discusses the use of growth hormone in children with Prader-Willi syndrome, the importance of multidisciplinary care and the future of treatment for this genetic condition.
Our podcast with consortium member, Stefano Cianfarani, from the University of Rome Tor Vergata, Italy, discusses the safety of growth hormone.
Childhood cancer survivors and endocrinopathies – the need for oncologist and endocrinologist collaboration
Our podcast with Dr Sogol Mostoufi, from the Children’s Hospital of Philadelphia in Pennsylvania, USA, focuses on the treatment-related endocrine side effects commonly experienced by childhood cancer survivors, and the need for screening, life-long follow-up and treatment in this high-risk population.
Research focus: ‘Health not height’ – Trial results for a targeted treatment for children with achondroplasia
Professor Ravi Savarirayan talks through the recently published results in The New England Journal of Medicine for the C-type natriuretic peptide analogue vosoritide in children with achondroplasia.
In this podcast, Dr Shylaja Srinivasan discusses the care of children and adolescents with type 2 diabetes, and how the findings of the TODAY2 and Ellipse trials will inform treatment decisions.
In our first edition, Professor Frederic Castinetti discussing the results of an international collaboration to study the natural history and treatment outcomes of multiple endocrine neoplasia type 2B, and Professor Martin Savage comments on a randomized trial of letrozole versus testosterone in boys with constitutional delay of growth and puberty.